Literature DB >> 31335203

Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature.

Stefan Pleus1, Sina Ulbrich1, Eva Zschornack1, Stefanie Kamann2, Cornelia Haug1, Guido Freckmann1.   

Abstract

Background: The average wear time of continuous glucose monitoring (CGM) systems steadily increased over the last years. Increased wear times are likely achieved by using adhesives with a longer adherence time, which may have a more pronounced effect on the skin than adhesives with shorter adherence time.
Methods: In this project, a structured literature search was performed to assess how potential skin-related issues with CGM usage have been reported in scientific literature in the last 5 years. The literature search was performed with four search terms in the PubMed database.
Results: In sum, 279 articles were analyzed. Skin-related issues were mentioned in 19.0% of articles (53 out of 279). With respect to articles mentioning skin-related issues, CGM performance or efficacy was the study's main topic of most of these studies, whereas the minority used CGM as "add-on" to assess other objectives. There was a varying degree in how detailed skin-related issues were described and no uniform structured documentation was given. While some articles only described findings, other articles already documented final diagnoses, such as contact dermatitis. Furthermore, inconsistent wordings for comparable issues were used. The most frequent issues were pain, itching, erythema, bleeding, bruising, and allergic reactions.
Conclusion: To draw possible conclusions about the occurrence of skin-related issues during CGM use, more reports about skin-related issues in scientific literature are needed. A more detailed and uniformly structured documentation, possibly facilitated by a generally accepted guideline for structured descriptions, of skin-related issues could be helpful to enable clear differentiations between the described skin reactions.

Entities:  

Keywords:  Adhesives; Allergic reaction; CGM; Contact dermatitis; Skin irritation; Skin reactions

Mesh:

Substances:

Year:  2019        PMID: 31335203     DOI: 10.1089/dia.2019.0171

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  11 in total

1.  Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.

Authors:  Rachel S Rigo; Laura E Levin; Donald V Belsito; Maria C Garzon; Rachelle Gandica; Kristen M Williams
Journal:  J Diabetes Sci Technol       Date:  2020-05-09

2.  Analysis of the ADA's Standard of Diabetes Care Recommendation for Continuous Glucose Monitoring System.

Authors:  Jessica Hanae Zafra-Tanaka; Ana Brañez-Condorena; David R Soriano-Moreno; Alvaro Taype-Rondan
Journal:  J Diabetes Sci Technol       Date:  2020-08-29

3.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Richard I G Holt; J Hans DeVries; Amy Hess-Fischl; Irl B Hirsch; M Sue Kirkman; Tomasz Klupa; Barbara Ludwig; Kirsten Nørgaard; Jeremy Pettus; Eric Renard; Jay S Skyler; Frank J Snoek; Ruth S Weinstock; Anne L Peters
Journal:  Diabetologia       Date:  2021-12       Impact factor: 10.122

Review 4.  Use of continuous glucose monitoring in obesity research: A scoping review.

Authors:  Elizabeth Hegedus; Sarah-Jeanne Salvy; Choo Phei Wee; Monica Naguib; Jennifer K Raymond; D Steven Fox; Alaina P Vidmar
Journal:  Obes Res Clin Pract       Date:  2021-09-02       Impact factor: 5.214

5.  Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Authors:  Molly L Tanenbaum; Laurel H Messer; Christine A Wu; Marina Basina; Bruce A Buckingham; Danielle Hessler; Shelagh A Mulvaney; David M Maahs; Korey K Hood
Journal:  Diabetes Res Clin Pract       Date:  2021-09-14       Impact factor: 8.180

Review 6.  Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.

Authors:  Aileen Toner; Anna McCloy; Paula Dyce; Dilip Nazareth; Freddy Frost
Journal:  Cochrane Database Syst Rev       Date:  2021-11-29

7.  Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.

Authors:  Rodolfo J Galindo; Guillermo E Umpierrez; Robert J Rushakoff; Ananda Basu; Suzanne Lohnes; James H Nichols; Elias K Spanakis; Juan Espinoza; Nadine E Palermo; Dessa Garnett Awadjie; Leigh Bak; Bruce Buckingham; Curtiss B Cook; Guido Freckmann; Lutz Heinemann; Roman Hovorka; Nestoras Mathioudakis; Tonya Newman; David N O'Neal; Michaela Rickert; David B Sacks; Jane Jeffrie Seley; Amisha Wallia; Trisha Shang; Jennifer Y Zhang; Julia Han; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2020-09-28

8.  Extraction With Sweat-Sebum Emulsion as a New Test Method for Leachables in Patch-Based Medical Devices, Illustrated by Assessment of Isobornylacrylate (IBOA) in Diabetes Products.

Authors:  Herbert Fink; Nuno M de Barros Fernandes; Jörg Weissmann; Manfred Frey
Journal:  J Diabetes Sci Technol       Date:  2020-03-01

9.  Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management.

Authors:  Guido Freckmann; Sina Buck; Delia Waldenmaier; Eva Zschornack; Manuela Link; Nina Jendrike; Ines Obstfelder; Sara Vetrugno; Stefanie Kamann; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2020-03-22

Review 10.  Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.

Authors:  Trisha Shang; Jennifer Y Zhang; Andreas Thomas; Mark A Arnold; Beatrice N Vetter; Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.